Anxiety, Physiological Parameters, Patient Satisfaction and VR in Gynecological Oncology Surgery
Launched by HACETTEPE UNIVERSITY · Jun 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how virtual reality (VR) can help reduce anxiety in women who are about to undergo surgery for gynecological cancer. Many women feel anxious before surgery, which can affect their heart rate, blood pressure, and overall experience. The trial aims to see if using VR, which offers a calming and immersive experience, can lower anxiety levels and improve satisfaction with the preoperative process. Participants will be randomly assigned to either use VR before surgery or receive standard care without VR.
To be eligible for this trial, women must be at least 18 years old, have a confirmed diagnosis of gynecological cancer, and this must be their first surgery related to this diagnosis. They should also be able to understand and communicate in Turkish. If you join this study, you can expect to have your anxiety and physical responses measured before and after the VR experience or standard care, along with providing feedback on how satisfied you feel with the pre-surgery process. This research could help improve care for women facing gynecological cancer surgeries by finding effective ways to manage preoperative anxiety without medication.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • The participant must have a confirmed diagnosis of gynecological cancer.
- • The participant must be aware of their gynecological cancer diagnosis.
- • Participants must be 18 years of age or older.
- • Verbal and written informed consent to participate in the study must be obtained.
- • The participant must be able to communicate verbally and in writing in Turkish.
- • No communication impairments (e.g., visual, auditory, or cognitive) should be present.
- • This must be the participant's first surgical intervention related to gynecological oncology.
- • Eastern Cooperative Oncology Group (ECOG) Performance Status must not exceed 2.
- • The planned surgical procedure must be a laparotomy.
- Exclusion Criteria:
- • History of recurrent gynecological cancer.
- • Presence of vision problems that prevent the use of VR goggles, including participants who wear glasses or have uncorrected vision impairment.
- • Presence of conditions such as migraines, vertigo, active nausea, vomiting, or frequent headaches.
- • Sensitivity to motion sickness.
- • Diagnosis of a psychiatric condition, whether under pharmacological or non-pharmacological treatment.
- • Withdrawal of consent during the study.
- • Removal of the virtual reality headset during the intervention.
- • Development of any medical complications during the intervention period.
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Fatma Uslu Sahan, Assoc Prof
Principal Investigator
Hacettepe University Faculty of Nursing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported